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Abstract
Background: Among the primary goals of microarray analysis is the identification of genes that could distinguish between
different phenotypes (feature selection). Previous studies indicate that incorporating prior information of the genes’
function could help identify physiologically relevant features. However, current methods that incorporate prior functional
information do not provide a relative estimate of the effect of different genes on the biological processes of interest.
Results: Here, we present a method that integrates gene ontology (GO) information and expression data using Bayesian
regression mixture models to perform unsupervised clustering of the samples and identify physiologically relevant
discriminating features. As a model application, the method was applied to identify the genes that play a role in the
cytotoxic responses of human hepatoblastoma cell line (HepG2) to saturated fatty acid (SFA) and tumor necrosis factor
(TNF)-a, as compared to the non-toxic response to the unsaturated FFAs (UFA) and TNF-a. Incorporation of prior knowledge
led to a better discrimination of the toxic phenotypes from the others. The model identified roles of lysosomal ATPases and
adenylate cyclase (AC9) in the toxicity of palmitate. To validate the role of AC in palmitate-treated cells, we measured the
intracellular levels of cyclic AMP (cAMP). The cAMP levels were found to be significantly reduced by palmitate treatment and
not by the other FFAs, in accordance with the model selection of AC9.
Conclusions: A framework is presented that incorporates prior ontology information, which helped to (a) perform
unsupervised clustering of the phenotypes, and (b) identify the genes relevant to each cluster of phenotypes. We
demonstrate the proposed framework by applying it to identify physiologically-relevant feature genes that conferred
differential toxicity to saturated vs. unsaturated FFAs. The framework can be applied to other problems to efficiently
integrate ontology information and expression data in order to identify feature genes.
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Introduction
Current methods of feature selection can be classified into two
major categories: data-based and prior information-based. The
data-based techniques rely primarily on the microarray data and
sophisticated modeling or machine trained under the conditions of
supervised classification to identify the distinguishing features
(genes). The simpler ‘filtering’ techniques classify the subgroups by
maximizing the ratio of between-group to within-group variance.
Examples of filtering techniques include the Wilcoxon’s rank sum
test [1], Fisher’s Discriminant Analysis (FDA) [2,3], discriminative
partial least squares (PLS) [4] or genetic algorithm (GA)- [5] based
classification and clustering [6,7]. However, these techniques
suffer from certain drawbacks, e.g., many among them are based
on methods that require the genes to be independent and
uncorrelated, which microarray data is not [8]. Therefore,
improvements to the filtering techniques have been made, such
as ‘‘minimum redundancy and maximum relevance (mRMR)’’
[8]. Additionally, sophisticated ‘wrapper’ techniques have been
developed, which employ a trained learning machine to identify
the relevance of genes to a phenotype. Examples of wrapper
techniques include support vector machines (SVM) [9] and the
generalized least absolute shrinkage and selection operator
(LASSO) [10,11]. The wrapper methods are considered better
than the filter methods because they can incorporate the inter-
correlation of genes and can also determine the optimal number of
variables. A third set of techniques are also being developed which
combine the wrapper and the filter techniques (e.g. the kernel
Fisher discriminant analysis, KFDA) [12] or multi-layer percep-
trons [13]. There are two major shortcomings with the existing
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incorporate the vast amount of information already available on
the functions of the genes. Typically, the functional information of
the genes is employed only in the post-processing of the selected
genes. The incorporation of prior knowledge of genes is
particularly important when the expression data is noisy. Second,
most of the feature selection approaches belong to a family of
supervised discriminative analysis and therefore require labeling
information of the phenotypes (i.e., which phenotypes are in the
same group) to identify feature genes.
In order to address the first issue, alternative analysis methods
are being developed which incorporate prior information of the
genes [14–16]. In these knowledge-based methods, the association
of a pre-defined gene ontology (GO) category to a phenotype is
statistically evaluated, and used to identify the discriminating
cellular processes [17–19]. Such GO-based techniques identify the
gene sets and subsets which have significant association to a
phenotype. Individual genes which may be significantly altered
and have important association with the phenotype may not be
selected if the gene-group they belong to is not enriched. Even
among the subsets that are identified as important, the
identification of a few (one or two) targets can be difficult and
subjective. Another major drawback of these approaches is the
tedious manual preparation and updating of the data sets. While
data sets are available for Affymetrix chip for some species, for
other platforms, such as the custom cDNA microarrays, one would
need to manually define the gene sets, which can delay
procurement of downstream information or introduce errors.
Therefore, such techniques are useful when the expressions of
many genes of an important, causative pathway change. For other
situations where there is change of only a few, rate-controlling
genes, such approaches may not be as informative. Nevertheless,
applications of these techniques have lent support to the notion
that incorporation of prior knowledge could either improve the
classification efficiency or identify more relevant biological
processes. Regarding the second issue, a few recent studies have
aimed to combine unsupervised data clustering with feature
selection. In [20], the authors proposed altering the procedure of
data clustering and feature selection iteratively. In each iteration,
the data points are first clustered according to the selected features,
and then FDA is applied to identify a new set of features according
to the cluster labels. In [21,22], the iterative procedure is improved
by converting the original problem into a convex optimization
problem. However, none of these studies are able to exploit the
prior knowledge of the data, which is important with microarray
data analysis.
Here, we present a general framework for feature selection that
is able to overcome the two shortcomings simultaneously. The
proposed framework integrates the ontology information of the
genes with their expression data (X) to (a) perform unsupervised
data clustering to group similar cellular responses (Y) into clusters,
and (b) to identify the genes that are most discriminative among
the clusters of cellular responses. Mixture regression models are
first applied to cluster the multiple experimental conditions.
Important genes with high correlation to each group of
experimental conditions are then found by a regression model
that automatically incorporates the GO information. The key
genes that differentiate the groups of conditions are identified to
provide insight into the differences among the biological processes.
A major advantage of this method is the easy assimilation and
update of the functional information of the genes. Another major
advantage of the proposed method is that it unifies unsupervised
data clustering with supervised feature selection into a single
framework. This combination allows us to identify genes relevant
to multiple biological processes without having to know, a priori,
which experimental condition is related to which biological
process. This is important when conditions are difficult to classify
or the classification of conditions are unknown a priori.
Finally, the proposed method allows for parallel identification of
genes relevant to multiple cellular responses, which makes it an
efficient high-throughput analysis.
We demonstrated the proposed method by applying it to
identify the genes that are likely involved in the toxicity of FFAs, in
particular saturated (SFA), palmitate, and TNF-a. Our experi-
mental results showed that our proposed method is able to (a)
identify the group of toxic experimental conditions, and (b) identify
the genes that are relevant to the toxic conditions.
Methods
Bayesian Regression Model
The central assumption behind this method is that the genes
within a GO category would have similar effect on a cellular
response. Therefore, genes belonging to the same GO category
were constrained to have similar regression weights. The above
assumption may not always hold, by employing a restrictive
assumption, we aim to significantly reduce the hypothesis space of
the regression model. We believe that given a large number of
genes and a small number of experimental conditions, it is more
important to restrict the hypothesis space for data fitting. This
decision is also supported by our experimental results (below).
Additionally, in order to circumvent the noise typically associated
with microarray data, the gene expressions were approximated by
a multivariate Gaussian distribution and the regression weights
were estimated by minimizing the regression error that was
averaged over the Gaussian distribution.
Let X=(x1, x2,…, xm) denote the gene expression data for m
different experimental conditions, where xk=(x1, x2,…, xn)
represents the expression data of n genes under the kth condition.
Let y=(y1, y2,…, ym) denote the corresponding cellular responses
for the m conditions. By assuming that the conditional probability
Pr(y|X, w) follows the Gaussian distribution N(X
T w, s
2 I), the
regression error could be computed as
err w ðÞ ~
X m
i~1
yi{xT
i w
   2
~ y{XTw
       2
2 ð1Þ
where, w=(w1, w2,…, wn) are the regression weight assigned to the
n genes. The optimal solution for w that minimizes the above
regression error is
w~ XXT    {1
Xy ð2Þ
Now, consider multiple replicates of the gene expression data
under each experimental condition. Let x1
k, x2
k,…, xr
k denote the r
replicates of the gene expression data under the kth condition. We
can approximate the distribution of gene expression data under
the kth condition, i.e., Pr(xk), by a Gaussian distribution N(x ¯k, Sk)
where x ¯k and Sk are calculated as follows:
  x xk~
Pr
i~1 xi
k
r
, Sk~
X r
i~1
xi
k{  x xk
  
xi
k{  x xk
   T
ð3Þ
Due to the limited number of replicates (i.e., r is small for most
conditions), we simplify Sk as a diagonal matrix by setting the off-
diagonal elements of Sk to be zero. This is particularly important
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process, and the number of replicates is only two, which makes it
impossible to estimate any off diagonal elements in Sk. Using x ¯k
and Sk in (3), instead of regressing the cellular response to the
averaged gene expression data x ¯k, the Bayesian regression model
will search for the regression weights w that minimize the
following expected regression error:
Serr w ðÞ T~
X m
i~1
ð
yi{xT
i w
   2
Pr xi ðÞ dxi~ y{  X XTw
       2
2z
wT Xm
i~1 Sk
  
w
ð4Þ
where, X ¯ =(x ¯1, x ¯2,…, x ¯m). The optimal solution for the Bayesian
regression model is
w~   X X   X XTzS
   {1   X Xy ð5Þ
where, S~
Pm
i~1 Sk. Comparing the above expression for w to
the expression in (2), we see that the primary difference between
the two expressions is that (5) incorporates covariance matrix S
into its denominator. The introduction of S will assign smaller
regression weights to the genes whose expression data exhibit large
variance compared to the genes with small variance. Finally, genes
with the largest absolute regression weights are deemed to be the
most important genes and are selected for analysis. Note that
equation (5) is essentially similar to the ridge regression model. As
suggested by several studies (Roth, 2004), Lasso regression using
L1 norm tends to achieve better performance for feature selection.
However, the ridge regression is computationally more efficient
compared to Lasso regression. This is particularly important since
our approach employs an iterative algorithm to approximate the
optimal regression weights, and therefore efficient computation is
essential to our approach.
Mixture Model
The main idea behind the mixture models is to cluster the
experimental conditions into an optimal number of subgroups and
build a different regression model that relates the gene expression
data (X) to a cell response (Y) for each subgroup. The clustering of
experimental conditions, however, is based on their regression
weights. For example, two experimental conditions will be
grouped into the same cluster if they share similar regression
weights. However, the regression weights of each experimental
condition would also depend on the clustering results because a
regression model can be built only for a group of experimental
conditions. Hence, the technical challenge of regression mixture
model lies in resolving this dilemma. We applied Expectation
Maximization (EM) algorithm to effectively resolve this problem.
The key idea behind the EM algorithm is to iteratively alternate
the clustering and the regression procedures. At the very beginning
of the EM algorithm, experimental conditions are randomly
assigned to clusters and a regression model is built for each cluster.
Then, the regression weights obtained for the genes are used to
regroup the experimental conditions into a new set of clusters, and
the new clustering results are used to generate new regression
weights for the genes. The clustering and the regression
procedures alternate until a stable solution is reached where the
parameters no longer change with further iterations. It can be
shown that the EM algorithm described above will indeed
maximize the log-likelihood of the gene expression data.
Furthermore, the iterative procedure is guaranteed to converge
to a solution that is a local maximum [23].
In the regression mixture model, we don’t assume that all the
experimental conditions share the same regression weights w.
Instead, we assume that there are K (K,m) different sets of
regression weights, one for each sub-population. Each experimen-
tal condition will choose the most suitable set of regression weights.
Below, we outline the key idea behind the variational EM
algorithm that is used in our calculation.
We model the conditional probability Pr(y|X, w)b y
logPr yjX ðÞ ~
X m
i~1
logPr yijxi ðÞ ~
X m
i~1
log
X K
k~1
pkN xT
i wk,s2   
 !
ð6Þ
In order to incorporate the variance in the gene expression data,
similar to the Bayesian regression model, we compute the expected
log Pr(y|X) that is averaged over the distribution of the gene
expression data X. More specifically, the expected log Pr(y|X)i s
computed as
SlogPr yjX ðÞ T~
X m
i~1
ð
log
X K
k~1
qkN xT
i wk,s2   
 !
Pr xi ðÞ dxi ð7Þ
Where qk is the prior for choosing the kth regression model. To
facilitate the computation, we follow the idea of variational
method by introducing a variational distribution wi,k=Pr(k|yi, xi),
i=1,…,m, k=1,…, K and approximate the log-likelihood
expression in (7) as follows:
SlogPr yjX ðÞ T§
X m
i~1
X K
k~1
wi,k logqk{
1
2
log 2ps2   
{
1
2s2
ð
yi{xT
i wk
   2
Pr xi ðÞ dxi
  
~
X m
i~1
X K
k~1
wi,k logqk{
1
2
log 2ps2   
{
yi{  x xT
i wk
   2zwT
k Siwk
2s2
 !
ð8Þ
Thus, we have the following updating equations to compute wi,k,
qk, wk, and s
2
wi,k!qk exp {
yi{  x xT
i wk
   2zwT
k Siwk
2s2
 !
qk~
1
m
X m
i~1
wi,k
wk~
Xm
i~1 wi,k   x xi  x xT
i zSi
      {1 Xm
i~1 wi,kyi  x xi
  
s2~
X m
i~1
X K
k~1
wi,k yi{  x xT
i wk
   2
zwT
k Siwk
hi
ð9Þ
We further improved the robustness of the model by introducing
the prior for the regression weights Pr(wk) as a Gaussian
distribution N(0, l
21). Then, instead of maximizing the log-
likelihood, we will maximize the logarithm of the posterior
probability, i.e.,
logPr WjX,y ðÞ ~logPr yjX,W ðÞ zlogPr W ðÞ ð 10Þ
where, W=(w1, w2,…, wK). The updating equations in (9) are
unchanged except that the equation for wk is changed to the
following
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Xm
i~1 wi,k   x xi  x xT
i zSi
  
zlI
   {1 Xm
i~1 wi,kyi  x xi
  
ð11Þ
Evidently, the introduction of the uninformative prior is in general
to reduce the magnitude of the regression weights. As a result, the
small weights will become smaller and even zero, which could
result in a sparse solution for W.
We summarize the EM algorithm used in our calculation as
follows:
For t=1, 2, …
1. E-step: compute wi,k in (9) for each condition and every mixture
model
2. M-step: compute qk and s in (9), and wk in (11)
Incorporation of GO information into the similarity matrix
To incorporate the GO information into the regression model,
we first represent each gene by the set of GO terms that are
associated with the gene. We further expand the GO profile of
each gene by including the parent nodes of each associated GO
code. We then compute the similarity between two genes based on
the overlap between their GO profiles. Since some GO codes may
be more important than others, we adopt the term frequency
independent document frequency (TF.IDF) weighting scheme of
information retrieval and weigh each GO code by the IDF factor
when computing the gene similarity. The IDF factor for a GO
code g is computed as
IDF g ðÞ ~log
Nz0:5
Ng ðÞ
  
ð12Þ
where N is the total number of genes and N(g) is the number of
genes whose profile include the GO code g. The advantage of
using the IDF weight is that it down weighs the common GO
codes while computing gene similarity. This is based on the
assumption that a GO code is likely to be less important in
deciding the similarity between two genes if it is commonly shared
by a large number of genes. For example, the GO code
‘mitochondrial genes’ has many genes which belong to mitochon-
dria but may not be functionally related. We denote the pairwise
gene similarity by the matrix T=[Ti,j]n6n where element Ti,j
represents the similarity between the ith gene and the jth gene. We
would like to emphasize that the above assumption may not hold
in some biological processes. In particular, two genes sharing a
large similarity in their GO functions may show opposite effects on
regulating a phenotype. The situation could be even more
complicated when one gene up-regulates the expression levels of
certain genes under some conditions and down-regulates their
expression levels under other conditions.
Based on this assumption, we can construct an energy function
to measure the consistency between the assigned regression
weights w and the gene similarity T, as shown below:
l w,T ðÞ ~
X n
i,j~1
Ti,j wi{wj
   2~wTLw ð13Þ
where L is the graph Laplacian of similarity matrix T. Evidently,
the smaller the l(w, T) is, the more consistent the regression weight
w is to the gene similarity T. We can then incorporate the gene
similarity T into the regression model as a Bayesian prior for
regression weights W, i.e.,
Pr w ðÞ !exp {l
X n
i~1
w2
i {t
X n
i,j~1
Ti,j wi{wj
   2
 !
~
exp {wT lIztL ½  w
  
ð14Þ
Note that in the above, in addition to the prior for the gene
similarity T, we also include the uninformative prior through the
factor lI. The updating equations for the integrated Bayesian
regression mixture model are almost identical to the ones in (10)
except that the equation for wk is changed to the following:
wk~
Xm
i~1 wi,k   x xi  x xT
i zSi
  
zlIztL
   {1 Xm
i~1 wi,kyi  x xi
  
ð15Þ
User-specified parameters of the Integrative Mixture GO
(IMGO) model
The two user-specified parameters to our mixture model are l
and t. Parameter l is related to the uninformative prior and its
role is to reduce the variance in the regression weights. Given that
we have a large number of genes and relatively small number of
experimental conditions, there can be an infinite number of ways
to regress the cell response that are equally valid. The introduction
of the uninformative prior lI will allow us to distinguish among the
regression models that have the same regression error. In
particular, by increasing the value of the parameter l, we require
the regression model to assign large weights to only a small
number of genes and most genes are assigned very small or even
zero weights. In other words, l is used to control the volume of the
solution space for the regression weights. A large l will lead to a
smaller solution space and vice versa. The parameter t defines
the weight that is assigned to the GO information. The larger
the t, the more we require the regression weights to be
consistent with the GO information.
In addition to l and t, we also have to determine the number of
clusters when applying the mixture model. In our case, the number
of clusters is decided by the application. In particular, we have prior
knowledge that the experimental conditions can be classified into
toxic vs. non-toxic conditions. Hence, the experimental conditions
clustered naturally into two groups, in this application.
Extension to the Case When the Classification of
Experimental Conditions is Given
In the framework proposed above, we assume that the
classification of experimental conditions is unknown, which is
automatically discovered by the mixture model. In this section, we
demonstrate that the proposed framework can be easily extended
to scenarios where the classification of experimental conditions is
provided. We denote by ki,k the classification of the experimental
conditions: ki,k=1 indicates that the i-th experimental condition
belong to the k-th group of conditions, and zero otherwise. We
modify equation (15) by replacing wi,k, the group assignment
computed by the mixture model, with ki,k, the given classification
information for the experimental conditions. The resulting
expression for the regression weights is
wk~
Xm
i~1 ki,k   x xi  x xT
i zSi
  
zlIztL
   {1 Xm
i~1 ki,kyi  x xi
  
ð16Þ
We refer to this method as the ‘‘simpler method’’ to
differentiate it from the mixture regression model that is proposed
above.
GO Based Mixture Models
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Application to identify genes associated with fatty acid
toxicity to human hepatoma cell line
Free fatty acids and TNF-a have been suggested to play
important role in lipotoxicity. Yet, it is not clear which genes may
play a role in lipotoxicity in hepatocytes. Additionally, it is not
clear whether this interaction is affected by the type of free fatty
acids. It is known that exposure to elevated FFAs could cause
lipotoxicity, i.e., cell death associated with excessive lipid
accumulation or exposure. It has been also discovered that
saturated FFAs are more cytotoxic at elevated physiological
concentrations than the unsaturated FFAs. However, the under-
lying changes associated with the differential toxicity of saturated
and unsaturated FFAs are not clearly known. Additionally, TNF-a
is another factor that has been implicated in obesity-associated
disorders. We treated human hepatoma cell line, HepG2 cells,
with elevated physiological level (0.7 mM) of different types of
FFAs (saturated, monounsaturated and polyunsaturated)
‘‘crossed’’ with 3 different levels of TNF-a, 0, 20 and 100 ng/ml
for 24 h. Global gene expressions were measured by microarray
analyses. LDH release was measured as a marker of lipotoxicity. It
was observed that saturated FFA was much more toxic than
unsaturated FFAs and TNF exposure further increased the toxicity
of the saturated FFA (Figure 1A). Cells exposed to saturated FFAs
also had significantly higher ketone body release as compared to
Figure 1. The cytotoxicity and ketone body production in response to various treatments. Confluent HepG2 cells were treated for 24 h
with 0.7 mM of the indicated FFA complexed to 4% (w/v) BSA, in the presence or absence of TNF-a (0, 20 or 100 ng/ml). (A) Cytotoxicity of the
treatments. The cytotoxicity was measured as the % LDH released, as defined in the methods section. (B) Ketone body production. Acetoacetate and
beta-hydroxybutyrate release into the media were measured by enzymatic assays. Ketone body release was calculated as the sum of acetoacetate
and beta-hydroxybutyrate release. Data presented as mean6s.d. of three independent experiments. w, significant FFA effect, p,0.01, #, significant
TNF-a effect, p,0.01.
doi:10.1371/journal.pone.0003860.g001
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IMGO model to automatically identify the cytotoxic and
ketogenic conditions and the underlying gene changes that may
be associated with the differential cytotoxic response of liver cells
to the different types of FFAs and TNF-a.
We first conduct experiments using the simpler method by
assuming the classification of the experimental conditions is given.
We manually define the cytotoxic conditions and select the genes
using the computational model. The top five genes identified by
this analysis are shown in Table 1. We found that caspase 6, one of
the selected genes has been shown to play a role in the toxicity of
saturated FFAs to other cell type but not with our cell type (data
not shown). However, for the other four genes identified by the
simpler method, they have not been shown to play a direct role in
lipotoxicity according to existing literature [24–28]. Overall, the
results with the simpler method are mixed.
In the second experiment, we examined the proposed
framework without a priori knowledge of the classification of the
experimental conditions. First, we showed that the proposed
framework is able to identify the group of cytotoxic and ketogenic
conditions and the group of non-toxic conditions. This is
illustrated in Figure 2, in which a ‘‘separation’’ score, computed
based on the difference between the probabilities of assigning to
the two groups, is plotted for each experimental condition. We
clearly see that for all the cytotoxic and ketogenic conditions, their
separation scores are much larger than that of the non-toxic
conditions, indicating a clear separation between the two groups of
experimental conditions. This result indicates that the unsuper-
vised clustering method proposed in this paper is able to
automatically identify the experimental conditions that are in the
same group. The parameter values used for this analysis were:
lambda=0.5 and tau=3. The details of the selection of the
parameter values are provided in the supplementary file S1 and
supplementary figure S1.
Second, we examine the genes identified by the proposed
framework that are listed in Table 2. Lysosomal ATPases were
selected as the top genes. This identified an important role of
lysosomes in the toxicity of palmitate to the HepG2 cells. A
previous study [29] has shown that the cytotoxicity by palmitate to
hepatocytes could be reduced by reducing lysosomal permeabili-
zation. Another important gene identified by the analysis is
adenylate cyclase 9 (AC9). The selection of AC9 only for the cases
with high separation suggested that cAMP levels should be
differentially modulated by palmitate treatment and not by
unsaturated FFAs. This was indeed found to be the case
(Figure 3). Thus, the model was able to identify the genes that
are altered by saturated FFAs and play a role in the toxicity.
Discussion
Incorporation of functional information of the genes in the
microarray analysis is an active area of research. However, most of
the currently available methods utilize the prior functional (GO)
information to generate pre-defined sets of genes [17,18]. The
Table 1. Top 5 genes identified by supervised clustering-based model (‘‘simpler method’’).
Parameter Values LL id Name
l=0.5 3486 (gC) insulin-like growth factor binding protein 3 (IGFBP3), mRNA. (AA598601,NM_000598,Hs.77326)
t=3 3632 (gN) inositol polyphosphate-5-phosphatase, 40 kDa (INPP5A), mRNA. (T58773,NM_005539,Hs.124029)
10537 (gC) ubiquitin D (UBD), mRNA. (N33920,NM_006398,Hs.44532)
839 (gN) caspase 6, apoptosis-related cysteine protease (CASP6), transcript variant beta, mRNA. (W45688,NM_032992,Hs.3280)
51704 (gC) G protein-coupled receptor, family C, group 5, member B (GPRC5B), mRNA. (W35153,NM_016235,Hs.242407)
doi:10.1371/journal.pone.0003860.t001
Figure 2. Discrimination of cytotoxic conditions by the IMGO analysis. The ability of the two-population model for cytotoxicity to
distinguish the cytotoxic (high LDH release) conditions was tested.
doi:10.1371/journal.pone.0003860.g002
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altered by concerted changes in the expression of many genes of a
GO-category [17]. Though the approach presented here is
conceptually similar to these approaches, there are some major
differences. (a) Unlike most existing studies that are based on
supervised feature selection, our study applies unsupervised feature
selection. Specifically, we unified unsupervised data clustering with
supervised feature selection under the same framework, which
allows us to identify the feature genes even though the
classification of the experimental conditions is unknown. (b) The
similarity matrix employed in the analysis is based on the overlap
in the GO profiles among every pair of genes in the dataset.
Therefore, there are no strict gene sets and the possibility of
interaction/ coregulation of any pair of genes is incorporated as
well as weighted, i.e., genes with greater overlap in their GO-
profile have a greater coefficient in the similarity matrix and vice
versa. (c) One can control the contribution of the GO information
in the model. In our study, the contribution of the similarity matrix
(GO information) is weighted by the factor t, which can be varied.
This is in contrast to other methods where the GO information
takes precedence over the subsequent analysis. One disadvantage
of methods based centrally on GO information is that the prior
knowledge is typically generated for certain sets of conditions and
cell-types, so that the information generated may not be
universally valid (for every cell type and treatment condition).
Our experience has shown that there exists an optimal value of the
GO-contribution (t), beyond which the separation deteriorates.
This method allows one to take this into consideration and control
the GO-contribution to achieve the best discrimination among the
subpopulations.
As a representative application, we applied the model to identify
the genes associated with toxicity of saturated FFAs to human
hepatoma cells. We compared two alternatives for the proposed
framework- automatic (unsupervised) clustering and gene selec-
tion, and user-defined (supervised) classification and gene
selection. The latter is denoted above as the simpler method. As
Table 2. Top 5 identified genes by IMGO for various values of separation.
Parameter Values Separation LL id Names
l=0.5 0.9208 535 (gN) ATPase, H+ transporting, lysosomal V0 subunit a isoform 1 (ATP6V0A1), mRNA.
(AA430654,NM_005177,Hs.267871)
t=3 115 (gF) adenylate cyclase 9_(H64281,_,Hs.20196)
4792 (g) nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA), mRNA.
(W56300,NM_020529,Hs.81328)
9550 (gC) ATPase, H+ transporting, lysosomal 13 kDa, V1 subunit G isoform 1 (ATP6V1G1), mRNA.
(AA608567,NM_004888,Hs.90336)
1183 (gC) chloride channel 4_(AA019316,_,Hs.199250)
Mixture model with two sub-populations were fitted to the data for the values of the parameters l and t shown, and the difference in the probabilities of the two
models that fit the P-0 condition was calculated. For the choice of the parameters shown, the two models had very different probabilities that fit the palmitate
condition, whereby one model had a much greater probability than the other in fitting the palmitate results. For such scenario, genes with the greatest difference of
weights for the two populations are shown as they represent genes that have the greatest differential effect on the toxicity, or are responsible for differentiating the
toxic condition.
doi:10.1371/journal.pone.0003860.t002
Figure 3. Effect of FFA-treatments on intracellular cAMP levels. Cells were treated for 24 h with 0.7 mM of different types of FFA and the
levels of intracellular cAMP were measured. H=Control medium, O=0.7 mM oleate, L=0.7 mM linoleate, and P=0.7 mM palmitate. w,p ,0.01 by a
two-tailed t-test.
doi:10.1371/journal.pone.0003860.g003
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even though the equations identifying the genes (equations 15 and
16) are fairly similar. The key different between the unsupervised
method and the supervised one is that the unsupervised method
automatically computes probability wi,k in (15), which weights the
i-th experimental condition for the k-th group. As indicated in
Figure 2, this probability varies significantly across the experi-
mental conditions that are in the same group. On the other hand,
for the supervised method, the a priori classification information of
conditions is encoded by a binary variable ki,k, which gives the
same weight for all the experimental conditions that are in the
same group. We believe that the ability to weigh experimental
conditions in the same group differently leads to better gene
selection with the unsupervised method.
In conclusion, IMGO is a novel method to integrate prior
information and gene expression to identify feature genes which
play important role in a cellular phenotype/response as well as
those that are affected differently under different conditions.
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